Purpose of the Procedure
- Accurately differentiate between benign and malignant nodules.
- Avoid unnecessary diagnostic thyroid surgeries.
- Identify specific genetic mutations to tailor treatment plans.
This advanced genomic test revolutionizes thyroid nodule diagnosis by analyzing DNA/RNA to distinguish benign from malignant lesions, significantly reducing unnecessary surgeries and providing precise guidance for personalized clinical management.
Scientific name: Thyroid Nodule Molecular Profiling (ThyroSeq)
A sophisticated molecular test utilizing fine-needle aspiration (FNA) samples to analyze genetic mutations in indeterminate thyroid nodules, helping clinicians determine malignancy risk and avoid unnecessary surgical procedures.